Stock listing

Frankfurt:29A Amphastar Pharmaceuticals, Inc. Aktie

German listing (Frankfurt) of Amphastar Pharmaceuticals, Inc. · home listing NASDAQ:AMPH

Follow Amphastar Pharmaceuticals, Inc. into a list and get an email when it puts out news.

Share price · FWB:29A

€25.45 EUR -1.68 (-6.2%)

Close on Nov 20, 2026

Past year +16.2% · daily closes, Nov 20, 2025 – Nov 6, 2026, adjusted for splits
Day range
€25.03 – €25.45 EURNov 20, 2026
Market cap
€1.08B EURAt the close on Nov 20, 2026 · price × 42.54M shares outstanding
52-week range
€13.88 – €25.45 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
€2,435 EURMedian day 0 shares · 47 days with no trades · last 3 months, Aug 20, 2026 – Nov 6, 2026
Amphastar Pharmaceuticals, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:AMPH · Home$28.25 USD-1.46 (-4.9%)498,484$28.14$28.70$27.79$29.71Close on Nov 20, 2026
Frankfurt:29A€25.45 EUR-1.68 (-6.2%)—€25.03€25.45€25.03€27.13Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 6, 2026 · FWB:29A · EUR, adjusted for splits

DayCloseChange%OpenHighLowVolume
€25.16+0.888+3.7%€24.14€25.17€24.050
€24.28-0.30-1.2%€24.63€25.30€24.220
€24.58+0.626+2.6%€23.65€24.74€23.56160
€23.95-0.12-0.5%€23.73€24.09€23.390
€24.07+0.558+2.4%€24.45€24.52€23.95755
€23.51-0.11-0.5%€23.51€23.51€23.513,710
€23.62+1.265+5.7%€23.25€24.00€22.970
€22.36+0.067+0.3%€22.36€22.36€22.360
€22.29-0.068-0.3%€22.50€22.66€22.290
€22.36-0.24-1.1%€22.21€22.41€22.170
€22.60-0.069-0.3%€22.60€22.60€22.600
€22.67-0.068-0.3%€22.67€22.67€22.670
€22.74-0.119-0.5%€22.64€22.74€22.570
€22.85+0.121+0.5%€22.88€22.97€22.800
€22.73-0.136-0.6%€22.62€22.74€22.470
€22.87-0.437-1.9%€22.87€22.87€22.870
€23.31+0.679+3.0%€22.82€23.31€22.640
€22.63-0.838-3.6%€22.63€22.63€22.630
€23.47+0.272+1.2%€23.44€23.55€23.400
€23.19+0.653+2.9%€23.19€23.19€23.190
€22.54+0.244+1.1%€22.54€22.54€22.540
€22.30-0.337-1.5%€22.30€22.30€22.300
€22.63+0.027+0.1%€22.61€22.67€22.600
€22.61+0.38+1.7%€22.31€22.89€22.180
€22.23-0.057-0.3%€22.23€22.23€22.230
€22.28-0.024-0.1%€22.13€22.35€22.110
€22.31-0.902-3.9%€22.33€22.33€22.310
€23.21-0.267-1.1%€23.21€23.21€23.210
€23.48+1.37+6.2%€23.48€23.48€23.480
€22.11-0.59-2.6%€22.11€22.11€22.110
€22.70+0.547+2.5%€22.70€22.70€22.470
€22.15+0.825+3.9%€21.53€22.24€21.200
€21.32-0.0020.0%€20.99€21.37€20.99100
€21.33-0.287-1.3%€20.83€21.33€20.70100
€21.61+1.165+5.7%€20.35€21.63€20.020
€20.45+0.03+0.1%€20.38€20.48€20.27300
€20.42+0.471+2.4%€20.42€20.42€20.420
€19.95-0.281-1.4%€19.95€19.95€19.950
€20.23-0.557-2.7%€20.17€20.25€20.160
€20.79+1.101+5.6%€20.11€20.81€19.990
€19.68+0.299+1.5%€19.68€19.68€19.68500
€19.39+0.068+0.4%€19.39€19.39€19.390
€19.320.000.0%€19.41€19.44€19.040
€19.32-0.095-0.5%€19.29€19.41€19.250
€19.41-0.436-2.2%€19.41€19.41€19.410
€19.85-0.023-0.1%€19.85€19.85€19.852
€19.87+0.683+3.6%€19.87€19.87€19.870
€19.19+0.272+1.4%€19.19€19.19€19.190
€18.92+0.596+3.3%€18.92€18.92€18.920
€18.32+0.013+0.1%€18.32€18.32€18.320
€18.31-0.18-1.0%€18.31€18.31€18.31440
€18.49+0.082+0.4%€18.49€18.49€18.490
€18.41+0.456+2.5%€18.35€18.52€18.2961
€17.95+0.014+0.1%€17.95€17.95€17.950
€17.94-0.057-0.3%€17.94€17.94€17.940
€17.99-0.111-0.6%€17.99€17.99€17.990
€18.10+0.233+1.3%€18.10€18.10€18.100
Ticker
Frankfurt:29A
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
Frankfurt
Currency
EUR

What changed lately

Latest news

All Amphastar Pharmaceuticals, Inc. news

Amphastar Pharmaceuticals, Inc. on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
20 in the last 12 months · 133 in all · newest Nov 11, 2026 · oldest 2019
Calls
26 calls with a replay · 26 with a transcript · latest Nov 5, 2026
Decks
31 decks · latest Nov 5, 2026

Where Amphastar Pharmaceuticals, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:AMPH · Home listingNASDAQUnited StatesUSD
LS Exchange:A11664LS ExchangeGermanyEUR
gettex:29AgettexGermanyEUR
Lang & Schwarz:A11664Lang & SchwarzGermanyEUR
BOATS:AMPHBOATSUnited StatesUSD
Tradegate:29ATradegateGermanyEUR
Frankfurt:29A · This pageFrankfurtGermanyEUR
Dusseldorf:29ADusseldorfGermanyEUR
Munich:29AMunichGermanyEUR
Stuttgart:29AStuttgartGermanyEUR

Valuation

P/E 12.2× against a median of 36.5×: the lowest of 5 Pharmaceuticals companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$976.8M USD
P/E
12.2×
EV/sales
1.3×
EV/EBITDA
5.6×
Price/book
1.5×
Gross margin
46.8%
Operating margin
18.7%
Net margin
13.3%
Debt to equity
0.0×
Beta vs S&P 500
0.52

Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Amphastar Pharmaceuticals, Inc. · NASDAQ:AMPHUS$1.20BUS$976.8M12.2×1.3×5.6×1.5×13.3%0.0×0.52
Tianjin Chase Sun Pharmaceutical Co., Ltd. Class A · SZSE:300026US$1.30BUS$1.07Bn/an/an/a1.0×n/a0.0×n/a
Zhejiang Hisoar Pharmaceutical Co., Ltd. Class A · SZSE:002099US$1.30BUS$1.17Bn/a3.9×n/a1.9×−11.6%0.0×n/a
Concord Biotech Ltd. · NSE:CONCORDBIOUS$1.24BUS$1.19B40.6×9.4×27.3×5.5×24.1%0.0×n/a
Zhejiang Xianju Pharmaceutical Co., Ltd. Class A · SZSE:002332US$1.23BUS$1.07B17.7×1.9×n/a1.4×12.0%0.0×n/a
Hualan Biological Vaccine Inc. Class A · SZSE:301207US$1.16BUS$844.0M167×8.1×n/a1.5×6.6%0.0×n/a
Idorsia Ltd. · SIX:IDIAUS$1.15BUS$2.66Bn/a10.2×n/an/a−128.8%n/an/a
Chongqing Lummy Pharmaceutical Co., Ltd. Class A · SZSE:300006US$1.15BUS$1.03Bn/a9.6×n/a4.5×−16.6%0.1×n/a
Harrow, Inc. · NASDAQ:HROWUS$1.14BUS$1.36Bn/a4.5×188×39.1×−9.4%10.0×1.31
Changzhou Qianhong Bio-Pharma Co., Ltd. Class A · SZSE:002550US$1.12BUS$927.8M32.3×4.1×n/a2.7×15.3%0.0×n/a
GC Biopharma Corp. · KRX:006280US$1.11BUS$1.31Bn/a0.9×13.2×1.2×−2.5%0.3×n/a
Median of the othersUS$1.15BUS$1.12B36.5×4.5×27.3×1.9×−2.5%0.0×1.31

Forecasts

6 hold · 1 sell · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.

Price target
24.50 USD · Analysts' mean
EPS, year to Dec 2026
3.20 · 7 analysts
Revenue, year to Dec 2026
758.5M · 6 analysts

Team and board

Officers

OfficerRole
Jack ZhangChief Executive Officer, President, Chief Scientific Officer, and Director
Mary LuoChief Operating Officer, Chief Scientist, and Chairwoman of the Board of Director

Board

DirectorRole
Mary LuoChief Operating Officer, Chief Scientist, and Chairwoman of the Board of Director
Anthony T. PierceDirector
Bill PetersDirector
David R. GaughDirector
Diane G. GerstDirector
Gayle M. DeflinDirector
Howard LeeDirector
Jack ZhangChief Executive Officer, President, Chief Scientific Officer, and Director
Jacob LiawatidewiDirector
Michael A. ZasloffDirector
Richard PrinsLead Independent Director

Events

Calls

CallWhenStatus
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q3 2026 Earnings CallThu, Nov 05, 2026 · 5:00 PM ETReplay
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q2 2026 Earnings CallThu, Aug 06, 2026 · 5:00 PM ETReplay
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q1 2026 Earnings CallThu, May 07, 2026 · 5:00 PM ETReplay
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q4 2025 Earnings CallThu, Feb 26, 2026 · 5:00 PM ETReplay
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q3 2025 Earnings CallThu, Nov 06, 2025 · 5:00 PM ETReplay
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q2 2025 Earnings CallThu, Aug 07, 2025 · 5:00 AM ETReplay
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q1 2025 Earnings CallWed, May 07, 2025 · 5:00 PM ETReplay
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q3 2024 Earnings CallWed, Nov 06, 2024 · 5:00 PM ETReplay
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q2 2024 Earnings CallWed, Aug 07, 2024 · 5:00 PM ETReplay
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q1 2024 Earnings CallWed, May 08, 2024 · 5:00 PM ETReplay
All 26 calls
CallWhenStatus
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q4 2023 Earnings CallWed, Feb 28, 2024 · 5:00 PM ETReplay
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q3 2023 Earnings CallWed, Nov 08, 2023 · 5:00 PM ETReplay
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q2 2023 Earnings CallTue, Aug 08, 2023 · 5:00 PM ETReplay
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q1 2023 Earnings CallTue, May 09, 2023 · 5:00 PM ETReplay
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q4 2022 Earnings CallTue, Feb 28, 2023 · 5:00 PM ETReplay
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q3 2022 Earnings CallMon, Nov 07, 2022 · 5:00 PM ETReplay
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q2 2022 Earnings CallMon, Aug 08, 2022 · 5:00 PM ETReplay
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q1 2022 Earnings CallMon, May 09, 2022 · 5:00 PM ETReplay
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q4 2021 Earnings CallThu, Mar 10, 2022 · 5:00 PM ETReplay
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q3 2021 Earnings CallMon, Nov 08, 2021 · 5:00 PM ETReplay
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q2 2021 Earnings CallMon, Aug 09, 2021 · 5:00 PM ETReplay
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q1 2021 Earnings CallThu, May 06, 2021 · 5:00 PM ETReplay
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q4 2020 Earnings CallMon, Mar 15, 2021 · 5:00 PM ETReplay
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q3 2020 Earnings CallFri, Nov 06, 2020 · 12:00 PM ETReplay
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q2 2020 Earnings CallThu, Aug 06, 2020 · 5:00 PM ETReplay
Amphastar Pharmaceuticals (NASDAQ:AMPH) Q1 2020 Earnings CallThu, May 07, 2020 · 5:00 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 5, 2026 · After close+3.0%
Q2 2026Aug 6, 2026 · After close+4.9%
Q1 2026May 7, 2026 · After close−20.9%
Q4 2025Feb 26, 2026−27.7%
Q3 2025Nov 6, 2025 · After close−0.8%
Q2 2025Aug 7, 2025 · After close+10.1%
Q1 2025May 7, 2025 · After close+0.9%
Q4 2024Feb 26, 2025 · After close+0.9%
Q3 2024Nov 6, 2024 · After close−13.7%
Q2 2024Aug 7, 2024 · After close+13.3%
All 20 quarters
QuarterResultsShare move
Q1 2024May 8, 2024 · After close+0.5%
Q4 2023Feb 28, 2024 · After close−14.9%
Q3 2023Nov 8, 2023 · After close+15.4%
Q2 2023Aug 8, 2023 · After close−4.3%
Q1 2023May 9, 2023 · After close+13.0%
Q4 2022Feb 28, 2023 · After close+14.8%
Q3 2022Nov 7, 2022 · After close−9.4%
Q2 2022Aug 8, 2022 · After close−15.1%
Q1 2022May 9, 2022 · After close+7.0%
Q4 2021Mar 10, 2022 · After close+12.6%

Open Events

Decks

DeckKindSlidesDate
Q3 2026 Earnings PresentationEarnings27 slidesNov 5, 2026
Q2 2026 Earnings PresentationEarnings27 slidesAug 6, 2026
2026 Bank of America Health Care ConferenceConference27 slidesMay 13, 2026
25th Annual Needham Virtual Healthcare Conference (April 2026)Conference31 slidesApr 14, 2026
Barclays 28th Annual Global Healthcare Conference 2026Conference31 slidesMar 11, 2026
Piper Sandler 37th Annual Healthcare Conference 2025Conference30 slidesDec 3, 2025
Investor Presentation (August 2025)Investor deck26 slidesAugust 2025
Investor Presentation (May 2025)Investor deck26 slidesMay 2025
24th Annual Needham Virtual Healthcare Conference 2025Conference26 slidesApr 9, 2025
Investor Presentation (February 2025)Investor deck26 slidesFebruary 2025
All 31 decks
DeckKindSlidesDate
J.P. Morgan Healthcare Conference 2025Conference26 slidesJanuary 2025
36th Annual Piper Sandler Healthcare Conference (December 2024)Conference26 slidesDec 4, 2024
Jefferies London Healthcare Conference 2024Conference26 slidesNov 20, 2024
2024 Wells Fargo Healthcare ConferenceConference26 slidesSep 5, 2024
Jefferies Global Healthcare Conference 2024Conference26 slidesJun 6, 2024
Bank of America Health Care Conference 2024Conference26 slidesMay 15, 2024
Investor Presentation (February 2024)Investor deck26 slidesFebruary 2024
J.P. Morgan Healthcare Conference 2024Conference26 slidesJanuary 2024
Jefferies Healthcare Conference 2023Conference27 slidesJun 8, 2023
Merger or Acquisition (April 2023)Merger or acquisition11 slidesApr 24, 2023
Investor Presentation (February 2023)Investor deck27 slidesFebruary 2023
Piper Sandler 34th Annual Healthcare Conference (November 2022)Conference26 slidesNovember 2022
2022 Wells Fargo Healthcare ConferenceConference26 slidesSeptember 2022
Jefferies Healthcare Conference 2022Conference26 slidesJun 8, 2022
21st Annual Needham Virtual Healthcare Conference (April 2022)Conference26 slidesApr 12, 2022
J.P. Morgan Healthcare Conference 2022Conference26 slidesJanuary 2022
Jefferies 2022 London Healthcare ConferenceConference26 slides2022
Piper Sandler 33rd Annual Virtual Healthcare Conference 2021Conference26 slidesNovember 2021
2021 Wells Fargo Virtual Healthcare ConferenceConference23 slidesSep 9, 2021
Investor Presentation (August 2021)Investor deck24 slidesAug 26, 2021
Investor Presentation (January 2021)Investor deck23 slidesJan 12, 2021

Open Decks

IPO

Priced at US$7.00 a share on Jun 24, 2014.

Price
US$7.00 a share
Shares offered
8,000,000 shares of common stock · 4,640,000 from the company and 3,360,000 from selling shareholders
Offering size
US$56 million
Underwriters' option
Up to 1,200,000 more shares
Listing
AMPH on the Nasdaq Global Select Market
Underwriters
Jefferies, BMO Capital Markets, Piper Jaffray, Needham & Company · In the order on the cover
Shares delivered
On or about Jun 30, 2014

Steps

StepWhen
Draft sent to the SEC in confidenceDec 16, 2013
Filed publiclyMay 20, 2014
Amended 3 timesNewest Jun 18, 2014
Shares registered with an exchangeJun 18, 2014
Declared effective by the SECJun 24, 2014
Final prospectus, with the priceJun 25, 2014

Open IPO · From the cover of the final prospectus (424B4) filed Jun 25, 2014

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue719.9M732.0M644.4M499.0M437.8M349.8M322.4M294.7M240.2M255.2M
Cost of revenue363.8M358.1M293.3M250.1M238.0M206.5M190.4M187.7M149.7M151.0M
Gross profit356.1M373.9M351.1M248.9M199.7M143.3M131.9M107.0M90.5M104.2M
Research and development85.8M73.9M73.7M74.8M60.9M67.2M68.9M57.6M43.5M41.5M
Selling, general and administrative85.9M56.7M51.5M45.1M51.4M50.4M50.3M49.9M44.5M41.8M
Operating income140.4M205.4M197.0M107.5M69.9M11.0M-39.0K-8.62M-1.27M15.4M
Depreciation and amortization31.6M28.2M25.7M12.6M10.2M9.03M7.06M6.05M6.42M12.2M
EBITDA172.1M233.7M222.7M120.1M80.1M20.0M7.02M-2.57M5.15M27.5M
Interest expense25.5M30.3M27.2M1.85M885.0K374.0K119.0K243.0K826.0K1.02M
Income before tax123.6M189.8M171.4M116.0M84.1M4.64M60.2M-9.93M1.25M14.6M
Income tax25.5M29.7M31.8M23.5M20.6M3.54M13.7M-3.27M-2.40M4.81M
Net income98.1M159.5M137.5M91.4M62.1M1.40M48.9M-5.74M3.65M9.82M
Earnings per share, basic2.103.292.851.881.300.031.04-0.120.080.22
Earnings per share, diluted2.033.062.601.741.250.030.98-0.120.080.21

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents170.2M151.6M144.3M156.1M126.4M92.6M73.7M86.3M65.6M72.4M
Short-term investments112.6M70.0M112.5M19.7M10.3M13.0M11.7M2.83M2.63M527.0K
Receivables143.6M136.3M114.9M88.8M78.8M66.0M45.4M52.2M36.0M26.8M
Inventory176.9M153.7M105.8M103.6M92.8M96.8M110.5M69.3M63.6M79.8M
Current assets636.0M534.1M489.6M378.3M318.1M279.7M255.2M220.3M187.8M184.1M
Property, plant and equipment310.6M297.3M282.7M238.3M244.2M260.1M233.9M210.4M180.5M152.9M
Goodwill3.40M3.05M3.22M3.13M3.31M3.94M3.63M3.95M4.46M3.98M
Total assets1.63B1.58B1.51B742.0M671.5M631.2M587.0M513.6M451.1M427.7M
Accounts payable32.6M30.5M25.4M20.5M22.2M24.4M25.1M31.3M16.6M19.9M
Current liabilities158.2M173.8M225.4M94.9M103.8M112.2M90.0M106.8M67.2M60.6M
Long-term debt619.7M613.5M603.2M76.6M78.2M45.9M46.3M49.1M45.7M36.0M
Total debt621.3M613.8M603.6M79.7M80.4M58.2M54.1M50.2M47.2M37.7M
Total liabilities840.5M845.2M873.5M213.3M226.0M182.5M159.4M149.2M117.3M98.5M
Shareholders' equity788.8M732.3M639.4M528.7M445.5M402.3M381.4M332.4M333.7M329.3M
Shares outstanding45.6M47.6M48.1M48.1M47.7M47.5M46.6M46.6M46.6M46.2M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations156.1M213.4M183.5M89.2M98.0M57.3M41.8M38.2M39.2M38.6M
Capital spending-34.9M-41.0M-38.2M-24.0M-27.5M-33.9M-41.6M-46.8M-35.1M-21.4M
Free cash flow121.2M172.3M145.3M65.1M70.5M23.4M207.0K-8.62M4.11M17.2M
Cash from investing-70.3M-124.9M-649.1M-32.8M-28.7M-36.4M-50.5M-42.2M-36.9M-39.5M
Cash from financing-67.4M-81.0M454.1M-26.4M-37.0M-2.25M-3.78M25.0M-7.72M7.14M
Dividends paid-454.1M-15.7M-15.9M-23.2M-20.3M0-10.2M
Share buybacks-75.6M-85.5M-58.1M-39.9M-28.9M-24.4M-22.3M-25.0M-30.7M-9.91M
Change in cash18.6M7.31M-11.8M29.7M32.1M19.0M-12.7M20.7M-4.89M6.28M

Open Financials

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 18, 2026Insider tradeSEC
144 · Notice of proposed saleNov 16, 2026Other filingsSEC
4 · Change in ownershipNov 6, 2026Insider tradeSEC
10-Q · Quarterly reportNov 5, 2026Quarterly reportSEC
8-K · Current reportNov 5, 2026ResultsSEC
144 · Notice of proposed saleNov 5, 2026Other filingsSEC
144 · Notice of proposed saleNov 4, 2026Other filingsSEC
4 · Change in ownershipSep 23, 2026Insider tradeSEC
144 · Notice of proposed saleSep 21, 2026Other filingsSEC
4 · Change in ownershipSep 17, 2026Insider tradeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipSep 3, 2026Insider tradeSEC
144 · Notice of proposed saleSep 1, 2026Other filingsSEC
144 · Notice of proposed saleAug 18, 2026Other filingsSEC
4 · Change in ownershipAug 12, 2026Insider tradeSEC
4 · Change in ownershipAug 11, 2026Insider tradeSEC
144 · Notice of proposed saleAug 11, 2026Other filingsSEC
144 · Notice of proposed saleAug 7, 2026Other filingsSEC
10-Q · Quarterly reportAug 6, 2026Quarterly reportSEC
8-K · Current reportAug 6, 2026ResultsSEC
SCHEDULE 13G · Big-stake noticeJul 14, 2026Big-stake noticeSEC
4 · Change in ownershipJul 13, 2026Insider tradeSEC
3 · Initial statement of ownershipJul 13, 2026Insider tradeSEC
8-K · Current reportJul 13, 2026Management or board changeSEC
8-K · Current reportJul 7, 2026Current reportSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
4 · Change in ownershipJun 3, 2026Insider tradeSEC
8-K · Current reportJun 3, 2026Meeting outcomeSEC
10-Q · Quarterly reportMay 7, 2026Quarterly reportSEC
8-K · Current reportMay 7, 2026ResultsSEC
ARS · Annual report to shareholdersApr 13, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 13, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 13, 2026Meeting noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 26, 2026Big-stake noticeSEC
4 · Change in ownershipMar 17, 2026Insider tradeSEC
4 · Change in ownershipMar 17, 2026Insider tradeSEC
4 · Change in ownershipMar 17, 2026Insider tradeSEC
4 · Change in ownershipMar 17, 2026Insider tradeSEC
8-K · Current reportMar 16, 2026Current reportSEC
4 · Change in ownershipMar 11, 2026Insider tradeSEC
4 · Change in ownershipMar 11, 2026Insider tradeSEC
4 · Change in ownershipMar 11, 2026Insider tradeSEC
4 · Change in ownershipMar 11, 2026Insider tradeSEC
4 · Change in ownershipMar 10, 2026Insider tradeSEC
4 · Change in ownershipMar 10, 2026Insider tradeSEC
4 · Change in ownershipMar 10, 2026Insider tradeSEC
4 · Change in ownershipMar 10, 2026Insider tradeSEC
4 · Change in ownershipMar 6, 2026Insider tradeSEC
4 · Change in ownershipMar 6, 2026Insider tradeSEC
4 · Change in ownershipMar 6, 2026Insider tradeSEC
4 · Change in ownershipMar 6, 2026Insider tradeSEC
8-K · Current reportMar 6, 2026Management or board changeSEC
8-K · Current reportMar 6, 2026Material contractSEC
10-K · Annual reportFeb 26, 2026Annual reportSEC
8-K · Current reportFeb 26, 2026ResultsSEC
8-K · Current reportJan 12, 2026Material contractSEC
4 · Change in ownershipDec 18, 2025Insider tradeSEC
4 · Change in ownershipDec 15, 2025Insider tradeSEC
144 · Notice of proposed saleDec 11, 2025Other filingsSEC
144 · Notice of proposed saleDec 10, 2025Other filingsSEC
144 · Notice of proposed saleNov 28, 2025Other filingsSEC
4 · Change in ownershipNov 25, 2025Insider tradeSEC
144 · Notice of proposed saleNov 25, 2025Other filingsSEC
4 · Change in ownershipNov 17, 2025Insider tradeSEC
144 · Notice of proposed saleNov 13, 2025Other filingsSEC
10-Q · Quarterly reportNov 6, 2025Quarterly reportSEC
8-K · Current reportNov 6, 2025ResultsSEC
4 · Change in ownershipNov 5, 2025Insider tradeSEC
144 · Notice of proposed saleNov 3, 2025Other filingsSEC
8-K · Current reportOct 24, 2025Material contractSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 17, 2025Big-stake noticeSEC
4 · Change in ownershipOct 2, 2025Insider tradeSEC
144 · Notice of proposed saleOct 1, 2025Other filingsSEC
8-K · Current reportSep 18, 2025Material contractSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
144 · Notice of proposed saleSep 2, 2025Other filingsSEC
8-K · Current reportAug 12, 2025Material contractSEC
10-Q · Quarterly reportAug 7, 2025Quarterly reportSEC
8-K · Current reportAug 7, 2025ResultsSEC
4 · Change in ownershipAug 4, 2025Insider tradeSEC
144 · Notice of proposed saleAug 1, 2025Other filingsSEC
4 · Change in ownershipJul 22, 2025Insider tradeSEC
3 · Initial statement of ownershipJul 22, 2025Insider tradeSEC
8-K · Current reportJul 21, 2025Management or board changeSEC
4 · Change in ownershipJul 3, 2025Insider tradeSEC
144 · Notice of proposed saleJul 2, 2025Other filingsSEC
4 · Change in ownershipJun 16, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
4 · Change in ownershipJun 4, 2025Insider tradeSEC
8-K · Current reportJun 3, 2025Meeting outcomeSEC
144 · Notice of proposed saleJun 2, 2025Other filingsSEC
4 · Change in ownershipMay 20, 2025Insider tradeSEC
10-Q · Quarterly reportMay 8, 2025Quarterly reportSEC
8-K · Current reportMay 7, 2025ResultsSEC
4 · Change in ownershipMay 2, 2025Insider tradeSEC
144 · Notice of proposed saleMay 1, 2025Other filingsSEC
ARS · Annual report to shareholdersApr 14, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 14, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 14, 2025Meeting noticeSEC
4 · Change in ownershipApr 2, 2025Insider tradeSEC
PRE 14A · Preliminary proxy statementApr 2, 2025Meeting noticeSEC
144 · Notice of proposed saleApr 1, 2025Other filingsSEC
4 · Change in ownershipMar 18, 2025Insider tradeSEC
4 · Change in ownershipMar 18, 2025Insider tradeSEC
4 · Change in ownershipMar 18, 2025Insider tradeSEC
4 · Change in ownershipMar 18, 2025Insider tradeSEC
4 · Change in ownershipMar 12, 2025Insider tradeSEC
4 · Change in ownershipMar 12, 2025Insider tradeSEC
4 · Change in ownershipMar 12, 2025Insider tradeSEC
4 · Change in ownershipMar 12, 2025Insider tradeSEC
4 · Change in ownershipMar 10, 2025Insider tradeSEC
4 · Change in ownershipMar 10, 2025Insider tradeSEC
4 · Change in ownershipMar 10, 2025Insider tradeSEC
4 · Change in ownershipMar 10, 2025Insider tradeSEC
4 · Change in ownershipMar 7, 2025Insider tradeSEC
4 · Change in ownershipMar 6, 2025Insider tradeSEC
4 · Change in ownershipMar 6, 2025Insider tradeSEC
4 · Change in ownershipMar 6, 2025Insider tradeSEC
4 · Change in ownershipMar 6, 2025Insider tradeSEC
144 · Notice of proposed saleMar 6, 2025Other filingsSEC
144 · Notice of proposed saleMar 4, 2025Other filingsSEC
10-K · Annual reportMar 3, 2025Annual reportSEC
8-K · Current reportFeb 27, 2025ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 7, 2025Big-stake noticeSEC
4 · Change in ownershipDec 16, 2024Insider tradeSEC
4 · Change in ownershipDec 11, 2024Insider tradeSEC
144 · Notice of proposed saleDec 9, 2024Other filingsSEC
4 · Change in ownershipNov 13, 2024Insider tradeSEC
4 · Change in ownershipNov 13, 2024Insider tradeSEC
4 · Change in ownershipNov 12, 2024Insider tradeSEC
144 · Notice of proposed saleNov 12, 2024Other filingsSEC
144 · Notice of proposed saleNov 12, 2024Other filingsSEC
4 · Change in ownershipNov 8, 2024Insider tradeSEC
4 · Change in ownershipNov 8, 2024Insider tradeSEC
10-Q · Quarterly reportNov 7, 2024Quarterly reportSEC
144 · Notice of proposed saleNov 6, 2024Other filingsSEC
144 · Notice of proposed saleNov 6, 2024Other filingsSEC
8-K · Current reportNov 6, 2024ResultsSEC
4 · Change in ownershipSep 17, 2024Insider tradeSEC
4 · Change in ownershipSep 16, 2024Insider tradeSEC
4 · Change in ownershipSep 6, 2024Insider tradeSEC
144 · Notice of proposed saleSep 5, 2024Other filingsSEC
8-K · Current reportAug 30, 2024Material contractSEC
4 · Change in ownershipAug 27, 2024Insider tradeSEC
144 · Notice of proposed saleAug 26, 2024Other filingsSEC
4 · Change in ownershipAug 13, 2024Insider tradeSEC
144 · Notice of proposed saleAug 12, 2024Other filingsSEC
10-Q · Quarterly reportAug 9, 2024Quarterly reportSEC
8-K · Current reportAug 7, 2024ResultsSEC
4 · Change in ownershipAug 2, 2024Insider tradeSEC
144 · Notice of proposed saleJul 31, 2024Other filingsSEC
4 · Change in ownershipJun 28, 2024Insider tradeSEC
144 · Notice of proposed saleJun 27, 2024Other filingsSEC
4 · Change in ownershipJun 11, 2024Insider tradeSEC
4 · Change in ownershipJun 11, 2024Insider tradeSEC
144 · Notice of proposed saleJun 10, 2024Other filingsSEC
4 · Change in ownershipJun 5, 2024Insider tradeSEC
4 · Change in ownershipJun 5, 2024Insider tradeSEC
4 · Change in ownershipJun 5, 2024Insider tradeSEC
4 · Change in ownershipJun 5, 2024Insider tradeSEC
4 · Change in ownershipJun 5, 2024Insider tradeSEC
4 · Change in ownershipJun 5, 2024Insider tradeSEC
4 · Change in ownershipJun 5, 2024Insider tradeSEC
8-K · Current reportJun 4, 2024Management or board changeSEC
144 · Notice of proposed saleJun 3, 2024Other filingsSEC
4 · Change in ownershipMay 21, 2024Insider tradeSEC
10-Q · Quarterly reportMay 9, 2024Quarterly reportSEC
8-K · Current reportMay 8, 2024ResultsSEC
4 · Change in ownershipMay 2, 2024Insider tradeSEC
144 · Notice of proposed saleMay 1, 2024Other filingsSEC
DEFA14A · Additional proxy materialApr 19, 2024Meeting noticeSEC
ARS · Annual report to shareholdersApr 12, 2024Annual reportSEC
DEFA14A · Additional proxy materialApr 12, 2024Meeting noticeSEC
DEF 14A · Proxy statementApr 12, 2024Meeting noticeSEC
4 · Change in ownershipApr 2, 2024Insider tradeSEC
144 · Notice of proposed saleApr 1, 2024Other filingsSEC
4 · Change in ownershipMar 19, 2024Insider tradeSEC
4 · Change in ownershipMar 19, 2024Insider tradeSEC
4 · Change in ownershipMar 19, 2024Insider tradeSEC
4 · Change in ownershipMar 19, 2024Insider tradeSEC
4 · Change in ownershipMar 8, 2024Insider tradeSEC
4 · Change in ownershipMar 8, 2024Insider tradeSEC
4 · Change in ownershipMar 8, 2024Insider tradeSEC
4 · Change in ownershipMar 8, 2024Insider tradeSEC
4 · Change in ownershipMar 6, 2024Insider tradeSEC
4 · Change in ownershipMar 6, 2024Insider tradeSEC
4 · Change in ownershipMar 6, 2024Insider tradeSEC
4 · Change in ownershipMar 6, 2024Insider tradeSEC
4 · Change in ownershipMar 6, 2024Insider tradeSEC
144 · Notice of proposed saleMar 6, 2024Other filingsSEC
SC 13G/A · Big-stake notice, amendedMar 6, 2024Big-stake noticeSEC
144 · Notice of proposed saleMar 5, 2024Other filingsSEC
4 · Change in ownershipMar 4, 2024Insider tradeSEC

This page holds 200 of 960 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Amphastar Pharmaceuticals, Inc.’s releases · as of Oct 30, 2026

Common shares
42,652,154
Fully diluted
42,652,154

Fully diluted

LineSharesAs of
Common shares42,652,154Oct 30, 2026

Share count over time

CountShares
Oct 30, 202642,652,154

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
BlackRock5.12M12.0%US$132MSep 30, 2026
Dimensional2.38M5.6%US$61.5MSep 30, 2026
Vanguard2.38M5.6%US$61.3MSep 30, 2026
State Street1.67M3.9%US$43.2MSep 30, 2026
American Century1.59M3.7%US$40.9MSep 30, 2026
Marshall Wace, LLP1.22M2.9%US$31.4MSep 30, 2026
D. E. Shaw & Co., Inc.1.15M2.7%US$29.6MSep 30, 2026
Geode Capital970K2.3%US$25.1MSep 30, 2026
Fuller & Thaler Asset Management, Inc.923K2.2%US$23.8MSep 30, 2026
Lsv Asset Management731K1.7%US$18.9MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Goldman Sachs595K1.4%US$15.4MSep 30, 2026
Renaissance Technologies531K1.2%US$13.7MSep 30, 2026
Systematic Financial Management LP479K1.1%US$12.4MSep 30, 2026
Morgan Stanley420K0.98%US$10.8MSep 30, 2026
Denali Advisors LLC387K0.91%US$9.98MSep 30, 2026
Bridge City Capital, LLC384K0.90%US$9.91MSep 30, 2026
Northern Trust355K0.83%US$9.15MSep 30, 2026
Bridgeway Capital Management, LLC339K0.80%US$8.76MSep 30, 2026
Hotchkis & Wiley Capital Management LLC336K0.79%US$8.67MSep 30, 2026
Schwab329K0.77%US$8.49MSep 30, 2026
Two Sigma299K0.70%US$7.72MSep 30, 2026
Hrt Financial LP298K0.70%US$7.69MSep 30, 2026
Algert Global LLC297K0.70%US$7.67MSep 30, 2026
First Trust292K0.68%US$7.54MSep 30, 2026
Principal261K0.61%US$6.75MSep 30, 2026
Balyasny Asset Management L.P.253K0.59%US$6.54MSep 30, 2026
Empowered Funds, LLC250K0.59%US$6.46MSep 30, 2026
BNY223K0.52%US$5.75MSep 30, 2026
O'Shaughnessy Asset Management, LLC199K0.47%US$5.57MSep 30, 2026
Bank of America197K0.46%US$5.09MSep 30, 2026
UBS187K0.44%US$4.82MSep 30, 2026
Invesco176K0.41%US$4.54MSep 30, 2026
AQR Capital Management LLC165K0.39%US$4.26MSep 30, 2026
Universal- Beteiligungs- und Servicegesellschaft mbH164K0.38%US$4.22MSep 30, 2026
Citadel132K0.31%US$3.41MSep 30, 2026
Lam Group, Inc.131K0.31%US$3.38MSep 30, 2026
Victory Capital129K0.30%US$3.34MSep 30, 2026
Arrowstreet Capital, Limited Partnership122K0.29%US$3.16MSep 30, 2026
Bessemer Group Inc121K0.28%US$3.13MSep 30, 2026
Nordea Investment Management AB116K0.27%US$3.06MSep 30, 2026
Public Sector Pension Investment Board107K0.25%US$2.84MSep 30, 2026
Nuveen89,5890.21%US$2.31MSep 30, 2026
Ameriprise83,2970.20%US$2.15MSep 30, 2026
Creative Planning81,8630.19%US$2.11MSep 30, 2026
Royce & Associates LP81,7820.19%US$2.11MSep 30, 2026
Legato Capital Management LLC79,5440.19%US$2.05MSep 30, 2026
Assetmark, Inc79,1240.19%US$2.04MSep 30, 2026
Rhumbline Advisers75,3760.18%US$1.95MSep 30, 2026
Legal & General71,9090.17%US$1.86MSep 30, 2026
Swiss National Bank64,8000.15%US$1.67MSep 30, 2026

This page holds 50 of 221 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
iShares Core S&P Small-Cap ETF2.05M4.8%US$41.3MJun 30, 2026
Vanguard Total Stock Market Index Fund1.06M2.5%US$21.3MJun 30, 2026
Avantis U.S. Small Cap Value ETF946K2.2%US$17.8MMay 31, 2026
Fullerthaler Behavioral Small Cap Equity903K2.1%US$18.2MJun 30, 2026
iShares Russell 2000 ETF848K2.0%US$17.1MJun 30, 2026
U.S. Small Cap Value Portfolio596K1.4%US$11.9MJul 31, 2026
Vanguard Extended Market Index Fund391K0.92%US$7.89MJun 30, 2026
Fidelity Small Cap Index Fund354K0.83%US$7.06MJul 31, 2026
State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF307K0.72%US$6.19MJun 30, 2026
iShares Russell 2000 Value ETF304K0.71%US$6.13MJun 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Dimensional U.S. Targeted Value ETF285K0.67%US$5.69MJul 31, 2026
U.S. Targeted Value Portfolio276K0.65%US$5.51MJul 31, 2026
Vanguard Tax-Managed Small-Cap Fund269K0.63%US$5.44MJun 30, 2026
State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF266K0.62%US$5.36MJun 30, 2026
Dimensional US Small Cap Value ETF256K0.60%US$5.11MJul 31, 2026
Pacer US Small Cap Cash Cows 100 ETF232K0.54%US$4.63MJul 31, 2026
First Trust Small Cap Core AlphaDEX Fund216K0.51%US$4.31MJul 31, 2026
U.S. Small Cap Portfolio210K0.49%US$4.19MJul 31, 2026
U.S. Micro Cap Portfolio192K0.45%US$3.84MJul 31, 2026
Vanguard Russell 2000 Index Fund184K0.43%US$3.48MMay 31, 2026
Fidelity Extended Market Index Fund184K0.43%US$3.48MMay 31, 2026
Applied Finance Explorer Fund181K0.42%US$3.61MJul 31, 2026
Schwab U.S. Small-Cap ETF171K0.40%US$3.22MMay 31, 2026
EA Bridgeway Omni Small-Cap Value ETF165K0.39%US$3.29MJun 30, 2026
iShares S&P Small-Cap 600 Growth ETF159K0.37%US$3.22MJun 30, 2026
iShares S&P Small-Cap 600 Value ETF141K0.33%US$2.85MJun 30, 2026
Vanguard S&P Small-Cap 600 Index Fund122K0.29%US$2.3MMay 31, 2026
Old Westbury Small & Mid Cap Strategies Fund121K0.28%US$2.41MJul 31, 2026
Vanguard Health Care Index Fund111K0.26%US$2.09MMay 31, 2026
State Street(R) SPDR(R) S & P 600(TM) Small Cap Growth ETF98,1500.23%US$1.98MJun 30, 2026
Dimensional U.S. Small Cap ETF97,9710.23%US$1.95MJul 31, 2026
Omni Small-Cap Value Fund89,1420.21%US$1.8MJun 30, 2026
iShares U.S. Pharmaceuticals ETF88,4930.21%US$1.79MJun 30, 2026
Royce Capital Fund - Small-Cap Portfolio84,0360.20%US$1.7MJun 30, 2026
VictoryShares Small Cap Free Cash Flow ETF81,0760.19%US$1.64MJun 30, 2026
State Street(R) SPDR(R) S & P 600(TM) Small Cap Value ETF80,2280.19%US$1.62MJun 30, 2026
Royce Small-Cap Fund79,0300.19%US$1.59MJun 30, 2026
Schwab Small-Cap Index Fund78,6220.18%US$1.57MJul 31, 2026
Fidelity Small-Mid Multifactor ETF77,5890.18%US$1.55MJul 31, 2026
ETC 6 Meridian Small Cap Equity ETF72,0830.17%US$1.36MMay 31, 2026
Fidelity Total Market Index Fund68,0750.16%US$1.28MMay 31, 2026
LSV Small Cap Value Fund62,1540.15%US$1.24MJul 31, 2026
Avantis U.S. Small Cap Value Fund61,5280.14%US$1.16MMay 31, 2026
Victory Small Cap Stock Fund60,9720.14%US$1.22MJul 31, 2026
Master Small Cap Index Series59,2350.14%US$1.2MJun 30, 2026
First Trust Small Cap Value AlphaDEX Fund59,2180.14%US$1.18MJul 31, 2026
Dimensional U.S. Core Equity 2 ETF57,5130.13%US$1.15MJul 31, 2026
Invesco RAFI US 1500 Small-Mid ETF56,4900.13%US$1.13MJul 31, 2026
Fidelity Series Total Market Index Fund53,9090.13%US$1.02MMay 31, 2026
JNL Small Cap Index Fund52,9790.12%US$1.07MJun 30, 2026

This page holds 50 of 246 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Peters William J
Director, Officer: CFO, EVP & TREASURER
Sale11,000USD 29.99US$330KNov 16, 2026
Peters William J
Director, Officer: CFO, EVP & TREASURER
Sale12,631USD 28.99US$366KNov 5, 2026
Peters William J
Director, Officer: CFO, EVP & TREASURER
Sale16,000USD 28.03US$448KNov 4, 2026
Peters William J
Director, Officer: CFO, EVP & TREASURER
Sale4,139USD 25.00US$103KSep 21, 2026
Zhou Rong
Officer: SENIOR EVP, PRODUCTION CENTER
Sale10,000USD 23.94US$239KSep 16, 2026
Zhou Rong
Officer: SENIOR EVP, PRODUCTION CENTER
Sale3,187USD 23.63US$75,309Sep 2, 2026
Prins Richard K
Director
Sale7,973USD 20.30US$162KAug 11, 2026
Peters William J
Director, Officer: CFO, EVP & TREASURER
Sale8,180USD 22.48US$184KAug 7, 2026

Big stakes

StakeStakeSharesDateFiling
Jack Y. Zhang24.80%12.5MDec 31, 2024Schedule 13G
BlackRock, Inc.11.50%5.33MSep 30, 2025Schedule 13G
Dimensional Fund Advisors LP5.20%2.31MJun 30, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Richard Prins
Other companies: IGC Pharma, Inc. (Chairman · Since at least Mar 31, 2025)
Lead Independent Director · Since at least Aug 19, 2024
Anthony T. PierceDirector · Since at least Jul 9, 2026
Bill PetersDirector · Since at least May 6, 2026
David R. GaughDirector · Since at least Jul 18, 2025
Diane G. GerstDirector · Since at least Jun 1, 2026
Floyd F PetersenDirector · Since at least Oct 4, 2017
Gayle M. DeflinDirector · Since at least Jun 1, 2026
Howard LeeDirector · Since at least Jun 3, 2026
Jack ZhangChief Executive Officer, President, Chief Scientific Officer, and Director · Since at least Aug 6, 2026
Jacob LiawatidewiDirector · Since at least May 27, 2026
All 14 people
PersonSeat
Marilyn J PurchaseCorp. Exec. VP of Operations · Jun 24, 2014 – Apr 9, 2015 · Past
Mary LuoCOO, Chief Scientist, Chairman, Director · Since at least Nov 13, 2017
Michael A. ZasloffDirector · Since at least May 16, 2022
Rong ZhouSENIOR EVP, PRODUCTION CENTER · Since at least Dec 1, 2023

Open People

Log in to ask 6ix AI your own questions about Amphastar Pharmaceuticals, Inc.